Yale University

Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care.

TitleParticipant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care.
Publication TypeJournal Article
Year of Publication2011
AuthorsChaudhry, Amina A., Michael Botsko, Linda Weiss, James E. Egan, Jennifer Mitty, Barbara Estrada, Gregory M. Lucas, Tanita Woodson, Timothy P. Flanigan, and David A. Fiellin
Corporate AuthorsBHIVES Collaborative
JournalJournal of acquired immune deficiency syndromes (1999)
Volume56 Suppl 1
PaginationS14-21
Date Published2011 Mar
ISSN1944-7884
KeywordsAdult, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Buprenorphine, Cross-Sectional Studies, Female, HIV Infections, Humans, Male, Methadone, Middle Aged, Naloxone, Narcotic Antagonists, Needle Sharing, Odds Ratio, Opiate Substitution Treatment, Opioid-Related Disorders, Risk-Taking, Unsafe Sex
AbstractThis study was part of a national, multisite demonstration project evaluating the impact of integrated buprenorphine/naloxone treatment and HIV care. The goals of this study were to describe the baseline demographic, clinical, and substance use characteristics of the participants and to explore HIV transmission risk behaviors in this group.
DOI10.1097/QAI.0b013e318209d3b9
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links